广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2014年
7期
861-864
,共4页
卢奎%吴文军%周敏%黎捷%钟健强%张成
盧奎%吳文軍%週敏%黎捷%鐘健彊%張成
로규%오문군%주민%려첩%종건강%장성
帕金森病%他莫昔芬%富含亮氨酸重复序列激酶2%小胶质细胞%肾上腺嗜铬瘤细胞
帕金森病%他莫昔芬%富含亮氨痠重複序列激酶2%小膠質細胞%腎上腺嗜鉻瘤細胞
파금삼병%타막석분%부함량안산중복서렬격매2%소효질세포%신상선기락류세포
Parkinson disease%Tamoxifen%Leucine-rich repeat kinase 2%Microglia%PC12 cell
目的:探讨他莫昔芬对小胶质细胞的富含亮氨酸重复序列激酶2( LRRK2)基因及相关炎症因子表达的影响。方法取原代小胶质细胞分为CON组、脂多糖( LPS)组、LPS+他莫昔芬组、LPS+LRRK2组;以LPS刺激激活小胶质细胞,用他莫昔芬调控小胶质细胞激活;将各组小胶质细胞与大鼠肾上腺嗜铬瘤细胞( PC12)细胞共培养24 h;Western Blot法检测小胶质细胞的LRRK2、一氧化氮合成酶( iNOS )表达,酶联免疫吸附法( ELISA)测定TNF-α、IL-1β水平;Hochest染核法检测PC12细胞凋亡/存活比。结果他莫昔芬抑制LPS刺激后小胶质细胞的LRRK2表达,通过抑制LRRK2下调iNOS、TNF-α及IL-1β释放,进而降低小胶质细胞与PC12细胞共培养体系炎症表达及PC12细胞凋亡/存活比。结论 LRRK2是小胶质细胞炎症因子iNOS释放的上游调控靶点,他莫昔芬可通过调控LRRK2基因抑制小胶质细胞激活,从而减轻炎症相关多巴胺能神经元损伤。
目的:探討他莫昔芬對小膠質細胞的富含亮氨痠重複序列激酶2( LRRK2)基因及相關炎癥因子錶達的影響。方法取原代小膠質細胞分為CON組、脂多糖( LPS)組、LPS+他莫昔芬組、LPS+LRRK2組;以LPS刺激激活小膠質細胞,用他莫昔芬調控小膠質細胞激活;將各組小膠質細胞與大鼠腎上腺嗜鉻瘤細胞( PC12)細胞共培養24 h;Western Blot法檢測小膠質細胞的LRRK2、一氧化氮閤成酶( iNOS )錶達,酶聯免疫吸附法( ELISA)測定TNF-α、IL-1β水平;Hochest染覈法檢測PC12細胞凋亡/存活比。結果他莫昔芬抑製LPS刺激後小膠質細胞的LRRK2錶達,通過抑製LRRK2下調iNOS、TNF-α及IL-1β釋放,進而降低小膠質細胞與PC12細胞共培養體繫炎癥錶達及PC12細胞凋亡/存活比。結論 LRRK2是小膠質細胞炎癥因子iNOS釋放的上遊調控靶點,他莫昔芬可通過調控LRRK2基因抑製小膠質細胞激活,從而減輕炎癥相關多巴胺能神經元損傷。
목적:탐토타막석분대소효질세포적부함량안산중복서렬격매2( LRRK2)기인급상관염증인자표체적영향。방법취원대소효질세포분위CON조、지다당( LPS)조、LPS+타막석분조、LPS+LRRK2조;이LPS자격격활소효질세포,용타막석분조공소효질세포격활;장각조소효질세포여대서신상선기락류세포( PC12)세포공배양24 h;Western Blot법검측소효질세포적LRRK2、일양화담합성매( iNOS )표체,매련면역흡부법( ELISA)측정TNF-α、IL-1β수평;Hochest염핵법검측PC12세포조망/존활비。결과타막석분억제LPS자격후소효질세포적LRRK2표체,통과억제LRRK2하조iNOS、TNF-α급IL-1β석방,진이강저소효질세포여PC12세포공배양체계염증표체급PC12세포조망/존활비。결론 LRRK2시소효질세포염증인자iNOS석방적상유조공파점,타막석분가통과조공LRRK2기인억제소효질세포격활,종이감경염증상관다파알능신경원손상。
Objective To study the effect of tamoxifen on the expressions of leucine-rich repeat kinase 2(LRRK-2) gene of microglia and related inflammatory factors .Methods Primary microglia was divided into 4 groups including control group,lipopolysaccharide(LPS) group,LPS plus tamoxifen group and LPS plus LRRK-2 group.LPS-activated microglia was regulated by tamoxifen .PC12 cells of rats were co-cultured with microglia for 24 hours in each group .The expressions of LRRK-2 gene and iNOS were detected by Western Blot .The levels of tumor necrosis factor α( TNF-α) and interleukin 1β(IL-1β) were tested by enzyme-linked immunosorbent assay ( ELISA).The apoptosis/survival ratio of PC12 cells was determined by Hochest staining .Results Tamoxifen down-regulated the LRRK-2 gene expression of microglia by LPS stimulation,inhibited the release of iNOS ,TNF-αand IL-1βby suppressing LRRK-2 gene,and decreased the co-cultured inflammatory expression of microglia and PC12 cells as well as apoptosis/survival ratio of PC12 cells.Conclusion LRRK-2 might be an upstream-regulated target for the release of iNOS in microglia .Tamoxifen can inhibit the activation of microglia by regulation of LRRK-2 gene,which might alleviate the inflammation-associated dopamine neuron injury .